interleukin-2 + interleukin-13

**interleukin-2 + interleukin-13** denotes a hypothetical or generic combination of two endogenous cytokines rather than a clearly established, specific drug product. Interleukin-2 is an immunostimulatory cytokine that activates and expands T cells and natural killer cells through the interleukin-2 receptor complex, while interleukin-13 is a type 2 helper T-cell cytokine that signals primarily through the interleukin-4 receptor alpha and interleukin-13 receptor alpha 1 receptor complex to modulate allergic inflammation, mucus production, macrophage polarization, and tissue remodeling. These cytokines have biologically distinct and often countervailing immune effects, and there is no well-defined approved pharmaceutical product, widely recognized development program, or standard clinical regimen consisting specifically of interleukin-2 plus interleukin-13 as a combination drug.

Other names

IL-2 + IL-13interleukin 2 + interleukin 13